Catalyst Event
Biogen Inc (BIIB) · Earnings Release
From KEDI Palantir Fixed Tech100 Index (KPLTT100)
5/7/2026, 12:00:00 AM
Biogen's Q1 2026 earnings release is expected around this date, based on past reporting schedules. Earnings releases typically result in moderate price volatility.
Korean Translation
과거 실적 발표일에 근거하여, 바이오젠의 2026년 1분기 실적 발표가 이 날짜 전후로 예상됨. 실적 발표는 통상적으로 주가에 중간 정도의 변동성을 야기함.
Related Recent Events
Broadcom Inc (AVGO) · Earnings Release
Q2 2026 earnings release on June 4, 2026; a Medium impact is estimated as quarterly earnings are key drivers of stock volatility, scheduled.
6/4/2026, 12:00:00 AM
Credo Technology Group Holding Ltd (CRDO) · Earnings Release
Next earnings release for Q4 fiscal 2026 on June 1, 2026, scheduled.
6/1/2026, 12:00:00 AM
Biogen Inc (BIIB) · Other
U.S. FDA PDUFA action date for the subcutaneous formulation of LEQEMBI for treatment initiation in early Alzheimer's disease is scheduled. This regulatory milestone is estimated to have a medium impact on stock price.
5/24/2026, 12:00:00 AM
Natera Inc (NTRA) · Earnings Release
Natera is expected to report its Q1 2026 earnings on May 7, 2026, with analysts forecasting an EPS of approximately -$0.55. Market impact is estimated at ≥1% as earnings dates are routine; scheduled.
5/7/2026, 12:00:00 AM
AppLovin Corporation (APP) · Earnings Release
AppLovin's Q1 2026 earnings release is scheduled.
5/6/2026, 12:00:00 AM
Microchip Technology Inc (MCHP) · Earnings Release
Q4 Fiscal Year 2026 earnings release including guidance for net sales of $1.26 billion +/- $20 million and non-GAAP diluted EPS of $0.48–$0.52. Low importance estimated as guidance is within expected ranges scheduled.
5/6/2026, 12:00:00 AM